biologic

Sucraid

sacrosidase

Loss of exclusivityApril 2010projected — 12-year biologic exclusivity estimate
CompanyQOL MedicalSee this company's full patent-cliff portfolio

Drug detail

Brand nameSucraid
Active ingredientsacrosidase
Strength1,003,000IU/118ML (8,500IU/ML)
Dosage formSolution For Oral
RouteOral
ModalityBiologic
FDA approvalApril 1998
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Sucraid patent cliff — loss of exclusivity April 2010 | CliffBio